Bristol Myers Squibb gets US FDA approval for Opdivo + Yervoy to treat unresectable MPM
The approval marks the third indication for Opdivo + Yervoy-based treatments in thoracic cancers and seventh indication overall
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.